This week we are joined by Jason Wild Chairman of TerrAscend to discuss :
- New Jersey Cannabis
- Terrascend’s east coast strategy
- Interstate commerce
- and so much more
TerrAscend is a global cannabinoid company that delivers new and innovative products, formulations, and brands focused on the needs of patients and consumers. In New Jersey, we are working to maximize positive impact through our cannabis cultivation facility and medical cannabis dispensaries. Our focus is to improve access to quality medical cannabis and education for patients in a welcoming, non-judgmental environment.
About Jason Wild:
Jason Wild is the President and Chief Investment Officer of JW Asset Management, LLC, and the advisor for five investment partnerships with over $2 billion in assets under management. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management, LLC in 1998. The firm has a strong history of finding opportunities within the healthcare sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy. Mr. Wild is the Chairman of the Board of TerrAscend Corp. and Arbor Pharmaceuticals. He is a board member of Vensun Pharmaceuticals and Vitruvias Therapeutics. Funds managed by JW Asset Management, LLC are the largest shareholders in TerrAscend Corp. Mr. Wild is also a board member of NETA NJ LLC where he will be actively involved in planning and directing the organization’s strategic and long-range goals.
At Eighth Revolution (8th Rev) we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain
Contact us directly at [email protected] Bryan Fields: @bryanfields24 Kellan Finney: @Kellan_Finney